Intrexon Corporation
Intrexon Corporation is developing DNA control systems to enhance the safety and efficacy of existing and novel biological therapeutics. The company's technology employs special genetic components and activator compounds to tightly control the delivery, targeting, activation, regulation and location of biologics. The goal of such DNA-mediated control is to improve the safety of those biologics while extending their clinical effectiveness. The company is currently engaged in clinical and pre-clinical studies related to solid tumor cancers and other intractable diseases that must be addressed with powerful biotherapeutic strategies. Together with its partners, Intrexon is committed to improving safety and clinical outcomes through the use of controllable biotherapeutics. For more information, please visit www.dna.com.
Synchrony, Inc.
Synchrony is a producer of magnetic bearings, power conversion, and control systems for large, industrialized customers. The company is dedicated to providing world-class products and services that improve the performance and environmental friendliness of rotating machinery through its proprietary magnetic levitation and power conversion technologies. Founded in 1993, Synchrony has received eight Small Business Innovation Research Awards from NASA and the Department of Defense. For more information, please visit www.synchrony.com.
LevelVision
With a broad international patent portfolio, LevelVision is a technology company that partners, designs and sells custom and commodity display systems for floor-based and counter-top digital media. Representing the value-adding frontier of place-based digital advertising and message delivery, LevelVision’s technologies are innovative, eye-catching, and represent a unique opportunity for customers or licensees to get their message to their intended audience in exactly the place the message needs to be delivered for optimum effect. With excellent consumer intercept response and Arbitron data to support the attention-grabbing nature of the technology, LevelVision is poised to leverage its products and partnerships into multiple market channels. For more information, please visit www.levelvision.com
Pinnacle Pharmaceuticals
Pinnacle Pharmaceuticals, Inc. is a specialty pharmaceutical company dedicated to the development of novel therapies in areas of significant unmet medical need. Pinnacle develops critical-care therapeutics for antibacterial, oncology, and pain management indications by leveraging its supramolecular chemistry platform and drug formulation expertise. Additionally, Pinnacle is advancing novel and potent synergistic compounds for current antibiotic regimes to treat patients suffering from infections refractory to the current gold-standard. Pinnacle is pursuing therapeutics for several infectious disease indications including methicillin resistant Staphylococcus aureus (MRSA) and vancomycin resistant enterococci (VRE). Pinnacle is rapidly progressing its lead compounds from the research laboratory into clinical development. For more information, please visit www.pinnaclepharmaceuticals.com
Keraderm
Keraderm Corp., headquartered in Blacksburg Virginia, is an early stage medical device company that has developed a patented, innovative, and effective treatment for nail infections. The treatment eliminates the potential serious side effects of current medications and has shown encouraging results in preclinical and early clinical testing. The Company believes that the ability to safely and effectively treat nail infections, the low cost, and the shortened treatment time of the Keraderm light-based solution will rapidly transform this billion-dollar-plus market. For more information, visit www.keraderm.com